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The tourniquet is routinely used in daily practice for upper and lower limb orthopedic 
surgery, in order to obtain a bloodless surgical field and thus, to allow a better visualization 
for the surgeon. Tourniquet use is associated to several local and systemic complications 
which can be disabling or even lethal, including pulmonary embolism, reperfusion injury, 
and permanent neurological damage. Several conditions can be considered as 
contraindications for the use of tourniquet, even though their classification either in relative 
or absolute contraindication group remains controversial. Those relative or absolute 
contraindications include deep vein thrombosis, atherosclerosis, vascular fragility (diabete 
mellitus, arteriopathies, vasculitis, calcified vessels, arterioveinous fistula, collagen 
vascular diseases, vascular prosthesis), cutaneous fragility, bone malunion, cerebral 
hypertension and cerebral trauma, sickle cell disease, rhumatoid arthritis, the presence of 
a local tumour or abcess, and cardiac or respiratory deficiency. The limb exsanguination 
should be performed by a simple elevation of the operated limb for 5 minutes. The 
tourniquet should be placed as distal as possible, and inflated to a pressure 50 to 75 
mmHg higher than the arterial occluding pressure, which should be calculated according to 
the Graham’s formula. Reperfusion periods of 10 minutes after every hour of ischemia are 
beneficial and thus can be implemented, but such reperfusion periods should be avoided if 
the ischemia lasted longer than 2 hours because they can become a factor aggravating 
the complications. Early after deflation, in the post-surgery minutes and hours, the 
neurological and vascular status of the operated limb should be carefully monitored in 
order to detect any potential complication as early as possible. The use of tourniquet is not 
harmless to the patient and thus should be objectively justified by the needs of the patient 
and only aimed at his own benefit. 
 
 




The word « tourniquet » is a French word derived from the French verb « tourner », which 
means « to turn ». By itself, the word « tourniquet » is used in French to name several 
objects sharing the common particularity of being useful when turning, going from the 
turning games for kids in kinder gardens, to the security turning doors at the entrance of 
football stadiums. Because of the structure of the first orthopedic tourniquets(a rope 
attached to a wooden stick, allowing a very strong narrowing of the rope around the limb 
by twisting the wooden stick), this word was also formerly used in French to describe the 
devices used by doctors and surgeons to interrupt the blood flow in a limb, either in the 
case of hemorrages in order to decrease blood loss, or to perform exsanguination during 
surgical procedures. While such devices are now called « garrot » in French, the word 
« tourniquet » is still used nowadays in English to name the different tools that are used to 
decrease blood loss during severe hemorrages (e.g special forces soldiers), or aimed at 
achieving limb exsanguination during surgical procedures (e.g pneumatic tourniquet). 
Such tools are routinely used in operating rooms, particularly in orthopedic and 
traumatology surgeries. The use of orthopedic tourniquets is not yet precisely guided by 
public health institutions (national and international ones) or medical societies guidelines, 
leaving the surgeon quite alone facing an important investigation field full of controversies 
and questions, going from precise technical details regarding the best use of this tool (e.g 
shape, inflation pressure, duration, releasing time) to the most basic and important one : 
« should I even use an orthopedic tourniquet ? ». The goal of this Graduation Paper is to 
give an overview of the advantages and disadvantages of tourniquet use in limb surgery, 
and to discuss it. 
II/ History of tourniquet development 
1) During antiquity 
The oldest written trace of an effort to prevent arterial bleeding is attributed to Sushrata. It 
is thought that he lived in India in the sixth century BC, and is sometimes referred as « the 
father of plastic surgery ». He is thought to have written the Sushrata Samhita, a surgery 
treatise written in Sanskrit mentionning 300 surgical procedures and 120 surgical tools and 
devices. Among those surgical procedures and tools is the description of pressed arteries 
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with pieces of leather in order to prevent from extensive bleeding. Some doubts remain 
regarding the existence of Sushrata, and the Sushrata Samhita may have been a 
collective production. But whoever were the authors of this surgery treatise, it remains the 
oldest written trace of an arterial compression used to control bleeding.  
In the ancient Greece, some documents attributed to the medical school that was founded 
by Hippocrates in Cos during the fifth century BC, describe compression dressings that 
were used to control bleeding. 
During Alexander the Great’s military campains in the fourth century BC, some devices 
were used by doctors and surgeons to interrupt or decrease the bleeding of wounded 
soldiers. 
In the Roman Republic and Empire, from the fifth century BC to the fifth century AC, 
probably as a consequence of military campains and gladiator’s fights, amputation 
techniques using some devices in order to decrease blood loss during the procedure were 
invented by doctors and surgeons. At these times, narrow straps made of bronze were 
used to compress limbs, using leather only for patient comfort. This is an important step in 
the tourniquet history, since it looks like it was the first time in the known human History 
that such a technique was not only used in emergencies and immediate life threatening 
situations, but was also used as a part of scheduled surgical procedures. (1) 
2) From middle age to our days 
A thousand years later, during the 16th century, Ambroise Paré, a french battlefield 
surgeon who became the personal surgeon of the french kings Charles IX and Henri III 
and who is sometimes called « the father of modern surgery », described the use of a 
knotted long string proximaly to an amputated limb during the amputation procedure. (2) 
(3). 
During the same period, Wilhelm Fabry (1560-1624), a german surgeon ; Morel, a french 
surgeon(1674) (1) (4) ; and James Yonge(1679), an english naval surgeon also sometimes 
known as James Young ; attached for the first time the constrictive bandage to a stick, 
giving the possibility to twist it and thus, to control the strenght of limb compression. 
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Simple wooden-stick tourniquet, also known as Morel tourniquet, allowing a very strong compression. 
(Source : Wikipedia) 
 
 
In 1718, the french surgeon Jean-Louis Petit invented a new device aimed at interrupting 
blood loss and displayed it at the Académie Royale des Sciences (royal academy of 
sciences). It was made of two metallic structures intended for limb compression, and 
linked to each other by two cloth bands. A screw on the top allowed a better control and an 
increased strenght of compression. Petit named it « tourniquet à vis » which means 
« screw tourniquet ». A clear advantage of the screw tourniquet was the opened possibility 
for the surgeon to operate alone, without the need of an assistant to hold the tourniquet to 
maintain the compression. (1) 
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Jean-Louis Petit type screw-tourniquet, allowing to maintain a constant compression force without the help of an 
assistant to hold the tourniquet. 
 
 
In 1864, the british surgeon Joseph Lister is thought to be the first one performing limb 
exsanguination by elevation for three to four minutes prior to tourniquet application, thus 
creating a bloodless operating field. Moreover, he is also the first one who used tourniquet 
for surgery procedures other than amputations. The first one has been the excision of a 
tuberculosis infected wrist joint, with the hope of preventing the patient from arm 
amputation by doing so. (1) 
In 1873, the german surgeon Friedrich von Esmarch, Professor of Surgery at the Kiel 
University, developed the use of flat rubber bandage to compress limb during surgical 
procedures, and gave his name to this technique. This approach has the advantage of 
associating exsanguination and prolonged compression in a single technique, and using 
only one tool. Esmarch bands are nowadays routinely used in daily practice in the 
operating room to perform exsanguination. 
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Esmarch bandage used prior to pneumatic tourniquet inflation in order to perform limb exsanguination. 
(Source : The Japanese Society for Cardiovascular Surgery website) 
 
 
In 1881, the german surgeon Richard von Volkmann demonstrated that despite its 
benefits, the use of Esmarch bandages can lead to limb paralysis in some cases. 
In 1904, the american neurosurgeon Harvey Cushing, sometimes called « the father of 
modern neurosurgery », invented the first pneumatic tourniquet in order to avoir the 
potential neurologic complications of Esmarch bandage use. This pneumatic tourniquet 
had the advantages of being applied and removed quite quickly, and to decrease the 
incidence of post-surgery nerve paralysis. 
In 1908, the german surgeon August Bier had the idea of using two tourniquets to isolate 
the blood circulation of a specific segment of a limb from the general circulation, before to 
infuse intravenous anesthetics. This principle of using two tourniquets to limit the 
spreading of anesthetics drugs in order to induce segmental anesthesia is still commonly 
used nowadays and is called « IntraVeinous Regional Anesthesia » (IVRA), also known as 
« Bier’s block » or « Bier’s method ». 
In the early 1980s, the canadian biomedical engineer James MacEwen invented the first 
microprocessor-controlled automatic tourniquet system and has been awarded for this 
contribution to limb surgery. This device allows to precisely control the applied pressure 
and can also measure the mean occlusion pressure for every patient, thus giving a strong 
surgical practice advantage, but also opening the research field to important issues such 
as investigations regarding ideal inflation pressure or ideal inflation duration 
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.  
Modern pneumatic tourniquet allowing a precise control of inflation pressure. 
(Source : Wikipedia) 
 
In the 2000s, the israeli Doctor Noam Gavriely invented the silicone ring tourniquet. It is 
made of an elastic silicone ring. It is put on the extremity of the operated limb and rolled on 
proximaly, thus exsanguinating the limb. Once the level of the intended occlusion reached, 
the silicone ring is kept in place. Just like the Esmarch bandage, this device has the 
advantage of being able to exsanguinate and maintain compression both together, but with 
a reduced risk of post-surgery nerve paralysis. Moreover, the device is sterile, allowing the 
avoidance of aseptia and antiseptia issues regarding operating room tools. 
III/ Basic pathophysiology of tourniquet use 
The use of tourniquet is a traumatic method, causing the onset of several local and 
systemic pathophysiological mechansims in the patients body. These mechanisms can be 
chronologically classified depending on their moment of arising : during exsanguination 
maneuvers, during tourniquet inflation, or during tourniquet deflation. These 
pathophysiological mechanisms and the potential subsequent complications will be 
extensively described below, in the following sections. 
1) Limb exsanguination 
The operated limb exsanguination may be performed by a simple and passive limb 
elevation, but is generally done by the use of an active device such as Esmarch bandage 
or Rhys-Davies exsanguinator. Such quite agressive technics have the advantage of being 
slightly more effective, but increase the risk of disseminating tumour cells or infection, and 
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of deep vein thrombosis dislodgement, potentially leading to fatal pulmonary embolism. (5) 
Moreover, it is interesting to remember that obtaining a total bloodless surgical field is 
possibe only if the operated segment is separated from the tourniquet by a joint. 
Otherwise, even with a proper occlusion of extraosseous circulation, some intraosseous 
blood supply remains. (6) 
2) Tourniquet inflation 
a)Hemodynamic consequences 
At the moment of tourniquet inflation, a systemic hypervolemia occurs due to prior 
exsanguination. This added blood volume is negligible in the case of a superior limb 
surgery (approximately 50 mL) but can be significant in the case of an inferior limb surgery 
(from 500 to 800 mL). In any case, the subsequent increase of arterial blood pressure is 
never significant and does not persit. (7) 
However, the occurrence of a delayed increased blood pressure happens secondarily to 
the tourniquet triggered pain. This modification is measurable 30 to 45 minutes after 
tourniquet inflation. (8) The measurement of cortisol and noradrenaline blood levels show 
some significant increased values of these two stress related hormones 60 minutes after 
tourniquet inflation, giving a clue of the existing link between the appearance of pain and 
the blood pressure increase. (8) 
b)Pain 
The pain is triggered by several factors not yet perfectly understood, but is caused by the 
activation of C fibers. Tissues compression, ischemia, and cutaneous trauma play a 
dominant role in tourniquet pain mechanisms. (7) Local anesthesia is more efficient than 
general anesthesia in this aspect, and can help to delay the onset of the pain and to 
decrease its intensity, thus preventing the pain triggered blood pressure increase. (9) (10) 
c)Thrombo-embolic processes 
The blood stasis caused by blood vessels occlusion leads to the accumulation of micro-
embolic particules in the operated limb, which are released in the systemic circulation at 
the tourniquet deflation. Moreover, the tourniquet inflation on a preexisting deep vein 
thrombosis can cause an immediate fatal pulmonary embolism. 
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d)Muscle lesions 
The tourniquet induced ischemia leads to the formation of necrotic areas in muscle tissue. 
Some small necrotic areas can be detected after 3 hours of tourniquet use, and extensive 
ones are detected 5 hours after tourniquet inflation. (11) The destruction of muscle tissue 
is objectively proven by an early increase of myoglobinemia and kalemia. A clinical picture 
of rhabdomyolysis and acute renal insufficiency has been described in few cases but 
remains an exception. (12) (13) 
e)Metabolic and pharmacokinetic consequences 
Hyperthermia develops in the whole body due to a decreased surface for thermic 
exchanges. (14) Inversely, the metabolic modifications and the absence of blood flow 
leads to hypothermia in the operated limb with tourniquet. 
Moreover, the hemodynamic separation from the rest of the body and the hypothermia of 
the operated limb prevents the induction anesthetic molecules to be washed out and 
metabolized. Those molecules are locally accumulated and stored, mostly in the muscle 
and adipose tissue of the operated limb. 
f)Cutaneous effect 
Cutaneous lesions are the consequences of direct contact of skin with tourniquet cuff, and 
are caused by the friction and abrasion forces which are applied directly to the skin. 
3) Tourniquet deflation 
The tourniquet deflation leads to the restoration of continuity between the operated limb 
and the rest of the body. This restoration has several local and systemic consequences. 
a)Hemodynamic consequences 
The revascularization of a previously exsanguinated limb and its vasodilation cause a 
decrease of the mean arterial pressure, which can drop to values inferior to 70% of the 
blood pressure at the time of deflation. However, this drop of blood pressure seems to be 
quite unpredictable nowadays in view of our current knowledge regarding this topic. (15) 
This significant decrease in blood pressure causes an increase of the heart rate. In the 
worst case scenario, a dramatic drop of the mean arterial pressure can lead to a 
distributive shock. 
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b)Systemic dissemination (thrombo-embolisms, tumour cells, septic particles) 
At the deflation of tourniquet, the accumulated micro-embolic particules are released in the 
systemic circulation and can be detected in 100% of cases. Trans-esophageal ultrasound 
and Doppler investigation detect an increase of right cardiac cavities blood pressure and of 
pulmonary vascular resistances few minutes after tourniquet deflation. (15) (16) As a 
consequence, the hemoglobin oxygen saturation percentage of the patient decreases as 
well in the moments following the deflation. (17) 
Subclinical cerebral embolisms are detected in 60% of cases after tourniquet deflation, 
and subclinical pulmonary embolisms in 100% of cases. A few severe or even fatal 
pulmonary embolisms have been described. (5) (18) (19) 
Not only thrombo-embolic particles, but also tumour cells and septic particles (coming from 
the disruption of an abcess due to the strong compression) can be released in the 
systemic circulation during deflation, potentially causing the metastatic spread of a cancer, 
distant infections, sepsis, or septic shock.  
c)Reperfusion injury 
The reperfusion injury (extensively described below) is characterized by the swelling of 
cells and an increase of capillary permeability, causing a leakage of liquid from the 
vascular compartment to the interstitial tissue. (20) Polynuclear leucocytes are recruited 
and their adhesion in the capillary lumen increase the arterioveinous shunt and thus, 
increase the tissue edema. (21) This post-ischemia edema is associated to the post-
traumatic edema (caused by the surgical agression) and to postoperative hemorrages. 
Those three mechanisms together lead to an extensive global increase of limb volume. 
The circumference of the operated limb can reach up to 150% of its initial lenght 24 hours 
after the procedure. (18) (19) If this multi-factorial edema is too large, it can lead to a no-
reflow phenomenon or to a compartment syndrome. 
d)Metabolic changes 
At the tourniquet deflation, the products of anaerobic metabolism are released in the 
systemic circulation. It causes a slight acidosis, with pH values usually not inferior to 7,30 , 
and increased PaCO2 and ETCO2. (22) In a patient operated with a local anesthesia, this 
acidosis is rapidly compensated by hyperventilation. This compensatory process needs a 
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longer time (4 to 5 minutes) to be effective in patients operated with a general anesthesia 
but is still efficient. Complications can arise in the case of patients with intra-cranial 
hypertension (e.g polytrauma) or with personal history of respiratory insufficiency 
(described in a following section). (23) 
The release in the systemic circulation of intracellular electrolytes from necrotic areas 
leads to an increase of potassium blood level. 
The restoration of blood circulation continuity causes a short period of hypothermia due to 
the low temperature of the ischemic limb, cooling down the rest of the body. This slight and 
short lasting hypothermia does not seem to have any significant clinical consequences. 
e)Local hematoma and skin lesions 
The damages caused by tourniquet use on blood vessels and muscle tissue leads to 
peroperative and postoperative hemorrages. The subsequent bruises and hematomas can 
be directly visibles on the skin, as well as the epidermal irritation and burns caused by the 
tourniquet cuff. 
IV/ Advantages 
The use of tourniquet in orthopedic limb surgery after passive or active exsanguination 
enables to obtain a partially exsanguinated limb and thus, a bloodless surgical field. This 
can be very important in the case of micro-surgical procedures to be able to visualize 
micro-anatomical structures. (19) (20) In other cases, when obtaining a bloodless surgical 
field is not absolutely necessary, the tourniquet is used for the operative comfort of the 
surgeon. 
The tourniquet use is sometimes said to be better for the hemodynamic function of the 
patient. As a matter of fact, only a few studies concluded that the use of tourniquet could 
decrease the peroperative blood loss. Moreover, even in these rare studies, the 
peroperative blood loss earning seems to be counterbalanced by an increased 
postoperative blood loss. Indeed, hypothermia, hypoxia and acidosis caused by the 
tourniquet induced ischemia lead to fibrinolysis, which increase the postoperative bleeding. 
(24) This is why the risk of post-surgery hemarthrosis is higher with tourniquet use. (25) 
Several studies have shown that the total blood loss in the case of tourniquet use is either 
globally similar or increased compared to surgeries without tourniquet.(26)(27)(28)(29)(30) 
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At last, it is also important to note that even if few studies have proved that tourniquet use 
decreases the duration of the surgical phase of the procedure (from incision to closure), 
this time earning is counterbalanced by an increased duration of other phases, such as the 
tourniquet preparation and installation. Thus, the duration of the whole procedure is not 
significantly decreased and does not save time for the surgeon, the hospital and the health 
care system. (31) 
Therefore, it looks like apart from some specific cases of microsurgeries, the only clear 
advantage of tourniquet use is the operative comfort of the surgeon during the procedure. 
V/ Disadvantages 
1) Systemic effects 
a) Pain and cardiovascular reactivity 
The pain and the cardiovascular modifications occuring in the setting of tourniquet use, 
seem to be closely related to each other. The mechanisms behind the tourniquet triggered 
pain are complexes. The nociceptive C fibers are involved in the occuring pain, but further 
investigations have to be done regarding this complex topic. (7) Studies on volonteers 
showed that without anesthesia, the tourniquet triggered pain becomes intolerable after 20 
to 30 minutes. (32) Under general anesthesia, an increase of cardiac rythm and arterial 
pressure is observed after 20 to 30 minutes of tourniquet use. This cardiovascular 
reactivity incresases with time, and a deeper general anesthesia does not interrupt this 
process. However, the local anesthesia clearly showed its efficacy in blocking this 
cardiovascular reactivity. (10) Nevertheless, even in the case of a proper and efficient local 
anesthesia, some tourniquet triggered pain and the associated cardiovascular reactivity 
can still arise if the tourniquet use duration lasts long enough. Indeed, the spinal plasticity 
causes an hyperextension phenomenon, best described as a progressive extension of 
cutaneous territories which are stimulated by the tourniquet. If this extension reaches 
tissues which are located proximaly to the anesthesized tissues, pain will occur. In daily 
practice, even in the case of a proper and efficient general anesthesia, pain can occur after 
60 to 80 minutes of tourniquet use as a consequence of hyperextension phenomenon. The 
appearence of this phenomenon can be delayed by the administration of opioids, (33) (34) 
adrenaline, (35) clonidine, (36) dextrometorphane, (37) dexmédétomidine, ketamine, (38) 
or by alcalinization of local anesthetic solutions when performing a nervous plexus block. 
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Furthermore, a short period of hypotension occurs at the moment of tourniquet deflation 
due to the restoration of vascularization continuity with the exsanguinated and vasodilated 
limb. A post-surgery hypovolemia occurs, secondary to vasodilation and to the increased 
vascular permeability during reperfusion. (18) (19) This hypovolemia can be worsened in 
the case of blood loss, either peroperative or caused by an other lesion(e.g polytrauma). 
b)Thrombo-embolic events 
The strong compression applied by the tourniquet on the operated limb is traumatic to all 
the underlying tissues, and blood vessels are not an exception. Thrombo-embolic events 
may happen, and can lead to a wide variety of consequences depending on their size, 
going from subclinical embolization only detected by Doppler investigation, to potentialy 
dramatic respiratory and neurologic complications. In the case of a preexisting deep vein 
thrombosis (due to a cast or to a prolonged pre-surgery immobilization), the appearance of 
a massive pulmonary embolism can arise at the beginning of the procedure during the 
exsanguination maneuvers, particularly if Esmarch bandage is used to exsanguinate the 
limb. (5) But thrombo-embolic events can also happen in the absence of preexisting deep 
vein thrombosis. Indeed, the veinous stasis caused by tourniquet use leads to an 
accumulation of micro-embolic particules. At the moment of tourniquet deflation, these 
accumulated micro-embolic particules are released in the systemic circulation and can 
cause pulmonary embolism. (5) (39) (40) A few massive and lethal pulmonary embolisms 
have been reported. (41) (42) Not only lungs but also brain can be damaged by such 
embolic migrations. Pulmonary embolism can cause pulmonary hypertension, thus 
causing an increased blood pressure in the right ventricule, leading to the opening of oval 
foramen and to a right-to-left shunt, potentially leading to cerebral paradoxal embolism, 
secondary to pulmonary hypertension. Obvious clinical strokes have been described 
rarely, but Doppler detected subclinical cerebral embolism have been found in up to 60% 
of patients after tourniquet deflation, even in the absence of an opened oval foramen. (43) 
However, the use of cement during orthopedic procedures probably has a role in embolic 
events, but this role is difficult to quantify. Moreover, some post-surgery clinical neurologic 
symptoms may have been caused by the neurotoxicity of cement. (44) 
c)Metabolic and respiratory consequences 
Apart from thrombo-embolic events, some respiratory consequences can also be caused 
by some metabolic reactions. 
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At the moment of tourniquet deflation, the products of anaerobic and hypoxic metabolism 
are released in the systemic circulation. The consequence of this release is an increase of 
PaCO2 and ETCO2. (22) In the case of a local anesthesia, this increase of carbonic acid 
level is not dangerous since a physiological adaptation occurs, causing hyperventilation, 
and eliminating quite fast the carbonic acid excess. In the case of a general anesthesia, 
this physiological adaptative hyperventilation is much slower, necessitating up to 5 minutes 
to come back to normal levels of carbonic acid. Even though this process lasts longer 
under general anesthesia compared to local anesthesia, it is most of the time very well 
tolerated by patients as long as they are otherwise healthy(apart from their orthopedic 
condition). However, in the specific case of a polytraumatic patient being operated while 
suffering from intracranial hypertension caused by a cranial trauma, the tourniquet release 
triggered hypercapnia can lead to a potentially lethal cerebral or cerebellar herniation. (23) 
Later on, the reperfusion injury phenomenon occurs. The local activation of polynuclear 
leucocytes and their production of Reactive Oxygen Species (ROS) can cause an Acute 
Respiratory Distress Syndrom (ARDS) due to pulmonary oxydative damage. The 
consequences of reperfusion injury can be particularly dangerous in the case of a patient 
with a personal history of chronic respiratory insufficiency. More details regarding the 
mechanisms involved in the reperfusion injury phenomenon will be explained below, in the 
part dealing with the local effects of tourniquet use. 
d)Pharmacokinetic complications 
The tourniquet use has some pharmacological consequences. Indeed, it is impossible 
anymore for the anesthetic drugs (curariform, opioids and antibiotic ones) to reach the 
operated limb from the moment of tourniquet inflation. In the opposite way, it is also 
impossible for the anesthetic drugs used for induction to be metabolized and cleared from 
the operated limb tissues. Those molecules are stored in the operated limb(mostly in 
muscles and adipose tissues) and remain almost not degraded due to hypoxia and 
hypothermia. (45) When the tourniquet is deflated, those induction moelcules are released 
in the systemic circulation and can cause a transient deepening of anesthesia, or even a 
depressed respiratory function in the 20 minutes following the deflation. (45) (46) 
The tourniquet use also have thermic consequences on the patients body. The tourniquet 
inflation separates the operated limb blood circulation from the systemic circulation. The 
entire operated limb cools down as long as the tourniquet is inflated. At the moment of 
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tourniquet deflation, the continuity of limb and systemic circulation is restored. This 
restored continuity of systemic circulation with colder blood and tissues transiently 
decreases the central temperature of the body. This could theoretically be an issue and 
has to be remembered, but did not show any problematic consequences in daily practice 
or in studies. 
2) Local effects 
a)Reperfusion injury, non-reperfusion 
The reperfusion injury is one of the most important local complication of tourniquet use. As 
explained above, at the moment of tourniquet deflation, the post-ischemia reperfusion 
causes recruitment and activation of polynuclear leucocytes, producing and releasing 
reactive oxygen species, potentially causing as a distant consequence an acute 
respiratory distress syndrom. Locally, the reperfusion injury leads to a reperfusion edema, 
which develops in two following phases. The first phase is a vasodilation immediately 
following the tourniquet deflation. This first phase is in general responsible from a 10% 
increase of limb circumference. The second edematous phase develops slower in the 
postoperative hours, and is caused by the activation of polynuclear leucocytes in hypoxic 
tissues, releasing cytotoxic agents damaging the capillary endothelium, thus increasing the 
capillary permeability in the post-ichemic operated limb. This second phase of reperfusion 
edema can be quite impressive since the limb volume increase can reach more than 150% 
of the initial limb volume at 24 hours after the surgery. (18) (19) 
In the worst cases, a no-reflow phenomenon can even occur, theatening the viability of the 
operated limb, potentially aggravated either by any external compression (e.g a cast) or by 
an impaired post-surgery hemodynamic status. (19) (20) 
b)Mechanical lesions (skin, muscles, nerves, blood vessels) 
The skin is the tissue which is in direct contact with the tourniquet cuff. Therefore, the 
strong pressure applied on the skin frequently cause cutaneous lesions, particularly if the 
tourniquet cuff is not perfectly installed and if some folds remain. Those cutaneous lesions 
are blisters most of the time and are spontaneously quite voluminous. The extent and the 
severity of those cutaneous lesions depends on several local factors(such as the 
tourniquet cuff proper installation, the inflation pressure and the prevention from antiseptic 
liquids flowing in between the skin and the tourniquet cuff), as well as structural factors(like 
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structural skin fragility, or an extreme age of the patient). (47) 
The mechanisms of muscular lesions is not perfectly understood yet, but it looks like a 
biological cascade is triggered by ischemia, involving ATP depletion, acidosis, electrolytes 
imbalance, cytokines and reactive oxygen species production, fast release of large 
amounts of calcium and mitochondrial dysfunctions, causing cellular apoptosis and tissue 
necrosis. The consequences are histologically detectable after one hour of tourniquet use. 
(48) After two hours, the histological investigations show the necrotic lesions in the 
compressed muscles. Those lesions are more severe in the case of higher inflation 
pressures, and can lead to clinical manifestations since postural instability and worse 
functional outcome have been reported. (48) (49) (50) (51) Some cases of rhabdomyolysis 
and acute kidney failure caused by compartment syndrom have been reported in the case 
of tourniquet use for more than 4 hours, but also for shorter procedures (45 to 120 
minutes) (18) (19) 
The compression forces are particularly important when talking about their consequences 
on neurologic system. The function of large diameter nervous fibers is impaired before the 
function of thinner ones. (52) Therefore, there is a chronological block of motor function 
followed by a sensitive block. (53) The mechanical deformation of thick myelinated fibers, 
associated with ischemia, leads to myeline sheath lesions, sometimes followed by 
demyelination and Wallerian degeneration. A short lasting compression (4 to 13 minutes) 
can be enough to impair nervous conduction. (54) Such abnormalities have been detected 
by electromyography during the use of tourniquet, and can persist until 6 months after the 
surgery. (50) Some cases of permanent lesions have even been descibed. (55) 
The high compression pressures are well tolerated by healthy arteries. But in the case of 
atheromatous lesion, the artery wall is fragile and loses its elastic properties, thus 
increasing the minimal arterial occlusion pressure (AOP). The applied pressure in order to 
occlude the vessels is higher, causing damages and rupture of vascular endothelium, and 
splitting of atheromatous plaques. Such rare complications in healthy patients are very 
frequent in polyatheromatous patients (up to 25%), and are extremely severe, leading to 
amputation if vascular reconstruction is not possible. (56) This is the reason why the 
revascularization of the operated limb has to be carefully checked immediately after 
tourniquet deflation by palpation of distal pulses, in order to detect any reperfusion 
impairment as soon as possible. (18) (19) 
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VI/ Discussion 
1) Optimal protocol in tourniquet use 
a)Exsanguination technique 
The two exsanguination techniques which are routinely used in limb surgery are the simple 
passive limb elevation, and the use of an active exsanguination device such as an 
Esmarch bandage.  
Such an aggressive technique has the advantage of being slightly more effective in 
exsanguinating the limb, but carries with it an increased risk of dramatic complication such 
as a severe to lethal pulmonary embolism, or a tumour dissemination. (57)  
Conversely, the passive exsanguination by simple limb elevation is slightly less effective 
but has the advantage of being easy to perform and safe. This approach is nonaggressive, 
and thus does not carry any thrombo-embolic or tumoral distant dissemination risk. It also 
does not imply the use of any device, thus decreasing therisk of postoperative infectious 
complications. At last, it allows a better visualization of superficial vessels compared to a 
complete and aggressive exsanguination, leading to a better hemostasis. (58) 
When performing this simple limb elevation technique, it is recommended to elevate the 
limb at 90 degrees for 5 minutes if it is an arm surgery, or at 45 degrees for 5 minutes if it 
is a leg surgery, in order to reach the maximal exsanguination. (59) (60) 
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b)Equipment: tourniquet shape, width, inflation pressure, regular check-up 
The shape of tourniquet cuff is important. A conical shaped tourniquet leads to a better 
distribution of pressures than a straight tourniquet, particularly in the case of obese or very 
muscular patients. The better pressure distribution on the limb reduces the arterial 
occlusion pressure, thus decreasing the incidence of pressure-related complications.  
 
A curved tourniquet allows a better distribution of pressure than a straight tourniquet, permitting a reduction in 
the arterial occlusion pressure. Sagittal forces are responsible for compression and axial forces are responsible 
for stretching, due to uneven pressure distribution. The intensity of stretching depends on the variation in 
sagittal pressure. 
(source :Estebe J-P, Davies JM, Richebe P. The pneumatic tourniquet : mechanical, ischemia-reperfusion and 
systemic effects. Eur J Anaesthesiol 2011 ; 28 :000-000) 
 
 
Following the same goal of reducing the pressure applied on the operated limb, it is also 
important to use a wide enough tourniquet cuff, leading to a decreased arterial occlusion 
pressure. It has been demonstrated than the arterial occlusion pressure decreases to 
values close to systolic pressure when the width of tourniquet is at least equal to 0,5 times 
the limb circumference. (32) (61) (62) In daily practice, if such a wide cuff is not available, 
the widest available cuff should be used, and its width should never be thinner than 0,3 
times the limb circumference. In those conditions, it should not be necessary to use 
inflation pressures higher than 100 mmHg above the systolic pressure for arm surgery. 
(63) (64) (62) (65) (66) Different strategies are used by surgeons to decide which inflation 
pressure they will apply on the patient limb. Regarding the fact that all the complications 
are somehow related to higher pressures, the use of the lowest efficient pressure should 
be a goal to achieve for the surgical and anesthesiological teams. The worst is the 
application of an arbitrary and constant pressure for any patient. A better strategy is to 
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apply an arbitrary but patient-adjusted inflation pressure (usually, 50 to 75 mmHg or 100 to 
150 mmHg above systolic pressure, for upper limb and lower limb respectively). (67) The 
optimal strategy is to determine the arterial occlusion pressure, using the Graham’s 
formula : 
AOP = [ (systolic pressure – diastolic pressure) (limb circumference) / 3 cuff width) ] + 
diastolic pressure (61) 
Then, the inflation pressure can be set at 50 to 75 mmHg above the calculated AOP. Using 
this approach, the applied pressures can be decreased by 20 to 40% in adults and by 
more than 50% in children, compared to the previously described arbitrary approaches. 
(65) (68) The blood pressure should be monitored during the procedure, and the inflation 
pressure should be adjusted accordingly. 
Since the applied pressure is the first risk factor for neurological lesions to happen with 
tourniquet use, it is of primary importance to implement and schedule some periodic 
verifications of the devices and frequent calibration. The absence of such verifications is 
usually found as being the cause when neurological lesions arise despite quite short 
surgery duration. (69) 
c)Tourniquet location and installation on the operated limb 
The tourniquet is frequently placed at the most proximal location of the limb, even when 
the operative site is distal. This should be reconsidered since several studies have shown 
good results with forearm tourniquet location in hand surgery, leading to decreased 
inflation pressures, and delayed and decreased pain. (63) (70) 
A wrinkle-free padding should be placed in between the skin and the tourniquet cuff in 
order to reduce skin damages due to shearing stresses. (71) A self adhesive plastic drape 
should be used to separate the tourniquet from the surgical field before skin preparation, in 
order to avoid chemical burns of the skin located beneath the tourniquet to arise. (72) (73) 
At last, the tourniquet cuff should not be moved once it has been inflated, thus avoiding 
shearing forces to damage underlying tissues. 
d)Tourniquet use duration and reperfusion periods 
The tourniquet use duration has to be as short as possible. However, no consensus has 
been established, probably in part because postoperative complications have been 
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reported even for tourniquet use duration much shorter than 2 hours. (69) An ideal duration 
would probably be shorter than 1 hour. (74) (75) (76) This technique has to be performed 
carefully since it seems that reperfusion after 1 hour of ischemia has a positive effect, but 
might be an aggravating factor after 2 hours of ischemia because after such a period, the 
pathophysiological processes and inflammatory cascade are greater than the biological 
mechanisms of protection. (77) 
Most of the authors recommend to plan some reperfusion periods of at least 10 minutes 
for every 45 to 60 minutes of tourniquet use, in order to decrease the incidence and 
severity of post-tourniquet complications. It is interesting to note that few authors strongly 
fight this approach, mostly because even though reperfusion periods seem to have a 
positive effect on the functional recovery of tissues located distally to the tourniquet, it 
looks like they can also exacerbate the lesions of tissues located beneath the tourniquet, 
particularly miscles. (69) (78) (79) 
e)Deflation and post-deflation monitoring 
In order to keep the ischemia duration as short as possible, it is better to deflate the 
tourniquet before hemostasis and closure. 
In the minutes and hours following deflation, it is of primary importance to regularly monitor 
the vascular and neurological status of the patient’s limb in order to detect the potential 
complications as early as possible. 
f)Prophylactic antibiotherapy 
Prophylactic antibiotherapy is used to prevent any post-surgery infectious complication. Its 
efficiency is maximal if the antibiotic drugs tissular concentration is the highest at the time 
of tourniquet inflation. It is interesting to remember that for cephalosporins, this spike level 
is reached 20 minutes after intreveinous injection. (80) 
2) Development of new therapeutic approaches 
a)Ischemic pre and post conditionning 
The mechanism of ischemic preconditioning has been discovered approximately 15 years 
ago. It can be described as a pathophysiological adaptation of a tissue to ischemia after 
having been previously exposed to short periods of ischemia and reperfusion, confering 
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him some ischemia resistance properties and thus decreasing the severity of lesions 
caused by a subsequent longer ischemia. The practical implementation of this concept can 
be done by imposing purposely three or four cycles of 5 minutes of ischemia(by inflating 
the tourniquet) followed by 5 minutes of reperfusion(by deflating the tourniquet). Those 
ischemia-reperfusion cycles have to be imposed to the tissue immediately before the 
beginning of surgical procedure. Ischemic preconditioning confers a increased ischemia 
resistance to local tissues located beneath and distal to the tourniquet, as well as a 
systemic resistance of distant organs such as lungs(also known as RIPC, Remote 
Ischemic PreConditioning). (81) (82) (83) (84) (85) (86)  
Ischemic postconditioning, described as intermittent repetitive interruptions of reperfusion 
after a prolonged ischemia, has been found to cause a comparable positive ischemia 
neuroprotective effect on spinal cord. (87) 
Ischemic pre and post conditioning are quite simple procedures with a potentially very 
strong positive effect regarding post-tourniquet ischemic lesions, and should probably be 
performed for any procedure with a tourniquet use estimated to two hours or more. 
b)Antioxydants 
Antioxydants have a protective effect, which is probably due to inhibition of polynuclear 
neutrophils recruitment, adherence and activation, and also to their reactive oxygen 
species scavenging properties. (88) (89) 
Inhalation of nitric oxyde before, during and after tourniquet use reduces inflammation in 
lower limb extremities. (90) (91) 
Heme oxygenase catalyses the breakdown of heme to several by-products including 
carbone monoxyde, which has similar anti-inflammatory properties than nitric oxyde. 
Allopurinol (an endothelial xantine oxydase inhibitor) and vitamine E(a reactive oxygen 
species scavenger) can decrease oxydative stress and edema in post-ischemic skeletal 
muscle. (75) 
Edaravone (an other reactive oxygen species scavenger), if given during early reperfusion, 
seems to be effective in reducing nerve injury due to oxydative stress. (92) 
Buflomedil and flurbiprofen can also be used to reduce post-tourniquet microvascular 
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reperfusion injury in striated muscle. 
c)Prevention of deep vein thrombosis 
Milrinone(a phosphodiesterase-3 inhibitor) can be used as an inodilator(positive inotrope 
and arteriovenous dilator) to reduce deep vein thombosis incidence. A peri-operative 
infusion of milrinone can decrease platelet activation without increasing the peri-operative 
blood loss. (93) 
VII/ Conclusion 
The use of tourniquet in limb surgery is associated to a lot of complications, arising at 
different times (exsanguination, tourniquet inflation, per-operative, tourniquet deflation, 
early and late postoperative), in different places (local area or distant and systemic), with a 
large range of severity (from subclinical ones to very severe and even lethal ones). 
Moreover, a lot of contraindications are mentioned by authors but without reaching a 
consensus regarding their classification either into absolute or relative contraindication 
categories. They include deep vein thrombosis, atherosclerosis, vascular fragility (diabete 
mellitus, arteriopathies, vasculitis, calcified vessels, arterioveinous fistula, collagen 
vascular diseases, vascular prosthesis), cutaneous fragility, bone malunion, cerebral 
hypertension and cerebral trauma, sickle cell disease, rhumatoid arthritis, the presence of 
a local tumour or abcess, and even cardiac or respiratory deficiency. From the patient 
prospect, those contraindications and potential complications are not counterbalanced by 
any clinical earnings or by a better outcome.  
The only clear advantage of tourniquet use is the operative comfort of the surgeon by 
obtaining a bloodless surgical field, but this is obviously very difficult, if not impossible, to 
objectively measure and quantify, not to mention the fact that this advantage is not aimed 
at the patient’s health. 
Performing hemostasis is not by itself an indication for tourniquet use since several other 
hemostasis technics have been proven to be much more effective. A few specific situations 
can be considered as proper indications for tourniquet use, such as some limb extremity 




Waiting to such guidelines, both surgical and anesthetic teams working with tourniquet 
should be well informed regarding tourniquet use contraindications, deleterious effects and 
complications, should know the limits of this tool, should be well informed regarding its 
optimal use and should be skilled accordingly. 
However, even in the optimal tourniquet use conditions, it is only possible to decrease 
incidence and severity of complications, which is not as good as avoiding them. The 
earnings being so little and exclusively aimed at the surgeon, it might be appropriate to 
reconsider the routine use of this technique. 
Medical Doctors nowadays still declame the hippocratic oath, and Medical schools all over 
the world are full of Hippocrates statues and quotes. One of the most famous of those 
Hippocrates quotes is in latin « primum non nocere », which can be translated in english 
by « firstly, no harm ». This basic principle of making sure not to cause harm even before 
to try to help, could leads us to a tremendous decrease of tourniquet use in limb surgery, 
and to keep this technic for few appropriate and accurate situations, when it is needed for 
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